nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—BCHE—Alzheimer's disease	0.276	0.685	CbGaD
Triamcinolone—BCHE—Rivastigmine—Alzheimer's disease	0.228	0.536	CbGbCtD
Triamcinolone—PTGS2—Alzheimer's disease	0.127	0.315	CbGaD
Triamcinolone—BCHE—Galantamine—Alzheimer's disease	0.117	0.276	CbGbCtD
Triamcinolone—CYP3A4—Rivastigmine—Alzheimer's disease	0.0346	0.0814	CbGbCtD
Triamcinolone—CYP3A4—Donepezil—Alzheimer's disease	0.0277	0.0651	CbGbCtD
Triamcinolone—CYP3A4—Galantamine—Alzheimer's disease	0.0178	0.042	CbGbCtD
Triamcinolone—Hiccups—Rivastigmine—Alzheimer's disease	0.000576	0.00435	CcSEcCtD
Triamcinolone—Dermatitis contact—Rivastigmine—Alzheimer's disease	0.00057	0.00429	CcSEcCtD
Triamcinolone—Candida infection—Memantine—Alzheimer's disease	0.000563	0.00424	CcSEcCtD
Triamcinolone—Skin exfoliation—Memantine—Alzheimer's disease	0.000563	0.00424	CcSEcCtD
Triamcinolone—Euphoric mood—Donepezil—Alzheimer's disease	0.000558	0.0042	CcSEcCtD
Triamcinolone—Neuropathy—Memantine—Alzheimer's disease	0.000553	0.00417	CcSEcCtD
Triamcinolone—Candida infection—Rivastigmine—Alzheimer's disease	0.00055	0.00415	CcSEcCtD
Triamcinolone—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.00055	0.00415	CcSEcCtD
Triamcinolone—Fluid retention—Rivastigmine—Alzheimer's disease	0.000547	0.00412	CcSEcCtD
Triamcinolone—Diabetes mellitus—Donepezil—Alzheimer's disease	0.000542	0.00408	CcSEcCtD
Triamcinolone—Neuropathy—Rivastigmine—Alzheimer's disease	0.000541	0.00408	CcSEcCtD
Triamcinolone—Muscular weakness—Galantamine—Alzheimer's disease	0.000536	0.00404	CcSEcCtD
Triamcinolone—Pulmonary oedema—Memantine—Alzheimer's disease	0.000524	0.00395	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.000519	0.00392	CcSEcCtD
Triamcinolone—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.000513	0.00387	CcSEcCtD
Triamcinolone—Injury—Donepezil—Alzheimer's disease	0.000512	0.00386	CcSEcCtD
Triamcinolone—Bronchitis—Galantamine—Alzheimer's disease	0.000505	0.00381	CcSEcCtD
Triamcinolone—Increased appetite—Donepezil—Alzheimer's disease	0.000501	0.00378	CcSEcCtD
Triamcinolone—Thrombophlebitis—Memantine—Alzheimer's disease	0.000494	0.00372	CcSEcCtD
Triamcinolone—Dermatitis bullous—Donepezil—Alzheimer's disease	0.000493	0.00372	CcSEcCtD
Triamcinolone—Diabetes mellitus—Memantine—Alzheimer's disease	0.000492	0.00371	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.000488	0.00368	CcSEcCtD
Triamcinolone—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.000483	0.00364	CcSEcCtD
Triamcinolone—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.000481	0.00363	CcSEcCtD
Triamcinolone—Vascular purpura—Memantine—Alzheimer's disease	0.000478	0.0036	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Memantine—Alzheimer's disease	0.000472	0.00356	CcSEcCtD
Triamcinolone—Osteoarthritis—Donepezil—Alzheimer's disease	0.000471	0.00355	CcSEcCtD
Triamcinolone—Vascular purpura—Rivastigmine—Alzheimer's disease	0.000468	0.00353	CcSEcCtD
Triamcinolone—Injury—Memantine—Alzheimer's disease	0.000465	0.00351	CcSEcCtD
Triamcinolone—Affect lability—Donepezil—Alzheimer's disease	0.000464	0.0035	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000459	0.00346	CcSEcCtD
Triamcinolone—Increased appetite—Memantine—Alzheimer's disease	0.000455	0.00343	CcSEcCtD
Triamcinolone—Injury—Rivastigmine—Alzheimer's disease	0.000455	0.00343	CcSEcCtD
Triamcinolone—Dermatitis bullous—Memantine—Alzheimer's disease	0.000447	0.00337	CcSEcCtD
Triamcinolone—Mood swings—Donepezil—Alzheimer's disease	0.000446	0.00336	CcSEcCtD
Triamcinolone—Increased appetite—Rivastigmine—Alzheimer's disease	0.000445	0.00336	CcSEcCtD
Triamcinolone—Purpura—Memantine—Alzheimer's disease	0.000444	0.00335	CcSEcCtD
Triamcinolone—Epistaxis—Galantamine—Alzheimer's disease	0.000442	0.00333	CcSEcCtD
Triamcinolone—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.000438	0.0033	CcSEcCtD
Triamcinolone—Purpura—Rivastigmine—Alzheimer's disease	0.000434	0.00327	CcSEcCtD
Triamcinolone—Bradycardia—Galantamine—Alzheimer's disease	0.000428	0.00323	CcSEcCtD
Triamcinolone—Osteoarthritis—Memantine—Alzheimer's disease	0.000428	0.00322	CcSEcCtD
Triamcinolone—Haemoglobin—Galantamine—Alzheimer's disease	0.000423	0.00319	CcSEcCtD
Triamcinolone—Rhinitis—Galantamine—Alzheimer's disease	0.000422	0.00318	CcSEcCtD
Triamcinolone—Affect lability—Memantine—Alzheimer's disease	0.000421	0.00317	CcSEcCtD
Triamcinolone—Haemorrhage—Galantamine—Alzheimer's disease	0.00042	0.00317	CcSEcCtD
Triamcinolone—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.000418	0.00315	CcSEcCtD
Triamcinolone—Muscular weakness—Donepezil—Alzheimer's disease	0.000415	0.00313	CcSEcCtD
Triamcinolone—Affect lability—Rivastigmine—Alzheimer's disease	0.000412	0.0031	CcSEcCtD
Triamcinolone—Abdominal distension—Donepezil—Alzheimer's disease	0.00041	0.00309	CcSEcCtD
Triamcinolone—Asthma—Donepezil—Alzheimer's disease	0.000407	0.00307	CcSEcCtD
Triamcinolone—Influenza—Donepezil—Alzheimer's disease	0.000407	0.00307	CcSEcCtD
Triamcinolone—Cardiac arrest—Memantine—Alzheimer's disease	0.000407	0.00307	CcSEcCtD
Triamcinolone—Mood swings—Memantine—Alzheimer's disease	0.000405	0.00305	CcSEcCtD
Triamcinolone—PTGS2—blood vessel—Alzheimer's disease	0.000403	0.0789	CbGeAlD
Triamcinolone—Pancreatitis—Donepezil—Alzheimer's disease	0.000399	0.00301	CcSEcCtD
Triamcinolone—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.000398	0.003	CcSEcCtD
Triamcinolone—Sweating increased—Donepezil—Alzheimer's disease	0.000397	0.00299	CcSEcCtD
Triamcinolone—Mood swings—Rivastigmine—Alzheimer's disease	0.000396	0.00299	CcSEcCtD
Triamcinolone—Bronchitis—Donepezil—Alzheimer's disease	0.000392	0.00295	CcSEcCtD
Triamcinolone—Muscular weakness—Memantine—Alzheimer's disease	0.000377	0.00284	CcSEcCtD
Triamcinolone—Arrhythmia—Galantamine—Alzheimer's disease	0.000376	0.00283	CcSEcCtD
Triamcinolone—Weight increased—Donepezil—Alzheimer's disease	0.000371	0.00279	CcSEcCtD
Triamcinolone—Asthma—Memantine—Alzheimer's disease	0.00037	0.00279	CcSEcCtD
Triamcinolone—Influenza—Memantine—Alzheimer's disease	0.00037	0.00279	CcSEcCtD
Triamcinolone—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000369	0.00278	CcSEcCtD
Triamcinolone—Pancreatitis—Memantine—Alzheimer's disease	0.000362	0.00273	CcSEcCtD
Triamcinolone—Sweating increased—Memantine—Alzheimer's disease	0.00036	0.00271	CcSEcCtD
Triamcinolone—Dysgeusia—Galantamine—Alzheimer's disease	0.000358	0.0027	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000358	0.0027	CcSEcCtD
Triamcinolone—Myocardial infarction—Donepezil—Alzheimer's disease	0.000356	0.00268	CcSEcCtD
Triamcinolone—Bronchitis—Memantine—Alzheimer's disease	0.000355	0.00268	CcSEcCtD
Triamcinolone—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000355	0.00267	CcSEcCtD
Triamcinolone—Back pain—Galantamine—Alzheimer's disease	0.000354	0.00267	CcSEcCtD
Triamcinolone—Conjunctivitis—Donepezil—Alzheimer's disease	0.000353	0.00266	CcSEcCtD
Triamcinolone—Sweating increased—Rivastigmine—Alzheimer's disease	0.000352	0.00266	CcSEcCtD
Triamcinolone—Bronchitis—Rivastigmine—Alzheimer's disease	0.000348	0.00262	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000344	0.00259	CcSEcCtD
Triamcinolone—Epistaxis—Donepezil—Alzheimer's disease	0.000342	0.00258	CcSEcCtD
Triamcinolone—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00034	0.00256	CcSEcCtD
Triamcinolone—Weight increased—Memantine—Alzheimer's disease	0.000336	0.00254	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000336	0.00253	CcSEcCtD
Triamcinolone—Bradycardia—Donepezil—Alzheimer's disease	0.000332	0.0025	CcSEcCtD
Triamcinolone—Malaise—Galantamine—Alzheimer's disease	0.00033	0.00249	CcSEcCtD
Triamcinolone—Weight increased—Rivastigmine—Alzheimer's disease	0.000329	0.00248	CcSEcCtD
Triamcinolone—Vertigo—Galantamine—Alzheimer's disease	0.000329	0.00248	CcSEcCtD
Triamcinolone—Syncope—Galantamine—Alzheimer's disease	0.000328	0.00247	CcSEcCtD
Triamcinolone—Haemoglobin—Donepezil—Alzheimer's disease	0.000328	0.00247	CcSEcCtD
Triamcinolone—Rhinitis—Donepezil—Alzheimer's disease	0.000327	0.00246	CcSEcCtD
Triamcinolone—Haemorrhage—Donepezil—Alzheimer's disease	0.000326	0.00246	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000325	0.00245	CcSEcCtD
Triamcinolone—Pharyngitis—Donepezil—Alzheimer's disease	0.000323	0.00244	CcSEcCtD
Triamcinolone—Myocardial infarction—Memantine—Alzheimer's disease	0.000323	0.00244	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000323	0.00244	CcSEcCtD
Triamcinolone—Loss of consciousness—Galantamine—Alzheimer's disease	0.000322	0.00243	CcSEcCtD
Triamcinolone—Conjunctivitis—Memantine—Alzheimer's disease	0.00032	0.00242	CcSEcCtD
Triamcinolone—Cough—Galantamine—Alzheimer's disease	0.000319	0.00241	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000318	0.0024	CcSEcCtD
Triamcinolone—Convulsion—Galantamine—Alzheimer's disease	0.000317	0.00239	CcSEcCtD
Triamcinolone—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000316	0.00238	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000316	0.00238	CcSEcCtD
Triamcinolone—Hypertension—Galantamine—Alzheimer's disease	0.000316	0.00238	CcSEcCtD
Triamcinolone—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000313	0.00236	CcSEcCtD
Triamcinolone—Myalgia—Galantamine—Alzheimer's disease	0.000312	0.00235	CcSEcCtD
Triamcinolone—Epistaxis—Memantine—Alzheimer's disease	0.000311	0.00234	CcSEcCtD
Triamcinolone—Discomfort—Galantamine—Alzheimer's disease	0.000308	0.00232	CcSEcCtD
Triamcinolone—Dry mouth—Galantamine—Alzheimer's disease	0.000305	0.0023	CcSEcCtD
Triamcinolone—SERPINA6—nervous system—Alzheimer's disease	0.000304	0.0596	CbGeAlD
Triamcinolone—Epistaxis—Rivastigmine—Alzheimer's disease	0.000304	0.00229	CcSEcCtD
Triamcinolone—Bradycardia—Memantine—Alzheimer's disease	0.000301	0.00227	CcSEcCtD
Triamcinolone—Haemoglobin—Memantine—Alzheimer's disease	0.000297	0.00224	CcSEcCtD
Triamcinolone—Rhinitis—Memantine—Alzheimer's disease	0.000297	0.00224	CcSEcCtD
Triamcinolone—Haemorrhage—Memantine—Alzheimer's disease	0.000296	0.00223	CcSEcCtD
Triamcinolone—Bradycardia—Rivastigmine—Alzheimer's disease	0.000295	0.00222	CcSEcCtD
Triamcinolone—Shock—Galantamine—Alzheimer's disease	0.000294	0.00222	CcSEcCtD
Triamcinolone—Pharyngitis—Memantine—Alzheimer's disease	0.000294	0.00221	CcSEcCtD
Triamcinolone—SERPINA6—central nervous system—Alzheimer's disease	0.000293	0.0574	CbGeAlD
Triamcinolone—Tachycardia—Galantamine—Alzheimer's disease	0.000292	0.0022	CcSEcCtD
Triamcinolone—Arrhythmia—Donepezil—Alzheimer's disease	0.000291	0.00219	CcSEcCtD
Triamcinolone—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000291	0.00219	CcSEcCtD
Triamcinolone—Rhinitis—Rivastigmine—Alzheimer's disease	0.00029	0.00219	CcSEcCtD
Triamcinolone—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000289	0.00218	CcSEcCtD
Triamcinolone—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000289	0.00218	CcSEcCtD
Triamcinolone—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000287	0.00217	CcSEcCtD
Triamcinolone—SERPINA6—cerebellum—Alzheimer's disease	0.000286	0.0561	CbGeAlD
Triamcinolone—Erythema—Donepezil—Alzheimer's disease	0.000284	0.00214	CcSEcCtD
Triamcinolone—Dysgeusia—Donepezil—Alzheimer's disease	0.000278	0.00209	CcSEcCtD
Triamcinolone—NR3C1—embryo—Alzheimer's disease	0.000278	0.0544	CbGeAlD
Triamcinolone—BCHE—forebrain—Alzheimer's disease	0.000276	0.054	CbGeAlD
Triamcinolone—Back pain—Donepezil—Alzheimer's disease	0.000274	0.00207	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000272	0.00205	CcSEcCtD
Triamcinolone—Insomnia—Galantamine—Alzheimer's disease	0.00027	0.00204	CcSEcCtD
Triamcinolone—Paraesthesia—Galantamine—Alzheimer's disease	0.000268	0.00202	CcSEcCtD
Triamcinolone—Arrhythmia—Memantine—Alzheimer's disease	0.000264	0.00199	CcSEcCtD
Triamcinolone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000263	0.00198	CcSEcCtD
Triamcinolone—Dyspepsia—Galantamine—Alzheimer's disease	0.000263	0.00198	CcSEcCtD
Triamcinolone—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000259	0.00195	CcSEcCtD
Triamcinolone—Fatigue—Galantamine—Alzheimer's disease	0.000258	0.00194	CcSEcCtD
Triamcinolone—Malaise—Donepezil—Alzheimer's disease	0.000256	0.00193	CcSEcCtD
Triamcinolone—Vertigo—Donepezil—Alzheimer's disease	0.000255	0.00192	CcSEcCtD
Triamcinolone—Syncope—Donepezil—Alzheimer's disease	0.000254	0.00192	CcSEcCtD
Triamcinolone—BCHE—telencephalon—Alzheimer's disease	0.000254	0.0497	CbGeAlD
Triamcinolone—Dysgeusia—Memantine—Alzheimer's disease	0.000252	0.0019	CcSEcCtD
Triamcinolone—Erythema—Rivastigmine—Alzheimer's disease	0.000252	0.0019	CcSEcCtD
Triamcinolone—Loss of consciousness—Donepezil—Alzheimer's disease	0.000249	0.00188	CcSEcCtD
Triamcinolone—Back pain—Memantine—Alzheimer's disease	0.000249	0.00188	CcSEcCtD
Triamcinolone—Cough—Donepezil—Alzheimer's disease	0.000248	0.00187	CcSEcCtD
Triamcinolone—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000247	0.00186	CcSEcCtD
Triamcinolone—Feeling abnormal—Galantamine—Alzheimer's disease	0.000246	0.00186	CcSEcCtD
Triamcinolone—Convulsion—Donepezil—Alzheimer's disease	0.000246	0.00185	CcSEcCtD
Triamcinolone—NR3C1—forebrain—Alzheimer's disease	0.000246	0.0481	CbGeAlD
Triamcinolone—Hypertension—Donepezil—Alzheimer's disease	0.000245	0.00185	CcSEcCtD
Triamcinolone—Back pain—Rivastigmine—Alzheimer's disease	0.000244	0.00184	CcSEcCtD
Triamcinolone—Myalgia—Donepezil—Alzheimer's disease	0.000242	0.00182	CcSEcCtD
Triamcinolone—PTGS2—embryo—Alzheimer's disease	0.00024	0.0471	CbGeAlD
Triamcinolone—Ill-defined disorder—Memantine—Alzheimer's disease	0.000239	0.0018	CcSEcCtD
Triamcinolone—Discomfort—Donepezil—Alzheimer's disease	0.000239	0.0018	CcSEcCtD
Triamcinolone—Dry mouth—Donepezil—Alzheimer's disease	0.000236	0.00178	CcSEcCtD
Triamcinolone—Body temperature increased—Galantamine—Alzheimer's disease	0.000236	0.00178	CcSEcCtD
Triamcinolone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000234	0.00176	CcSEcCtD
Triamcinolone—SERPINA6—brain—Alzheimer's disease	0.000233	0.0456	CbGeAlD
Triamcinolone—Malaise—Memantine—Alzheimer's disease	0.000232	0.00175	CcSEcCtD
Triamcinolone—Oedema—Donepezil—Alzheimer's disease	0.000232	0.00175	CcSEcCtD
Triamcinolone—Vertigo—Memantine—Alzheimer's disease	0.000231	0.00174	CcSEcCtD
Triamcinolone—Syncope—Memantine—Alzheimer's disease	0.000231	0.00174	CcSEcCtD
Triamcinolone—Infection—Donepezil—Alzheimer's disease	0.00023	0.00173	CcSEcCtD
Triamcinolone—Shock—Donepezil—Alzheimer's disease	0.000228	0.00172	CcSEcCtD
Triamcinolone—Malaise—Rivastigmine—Alzheimer's disease	0.000227	0.00171	CcSEcCtD
Triamcinolone—Vertigo—Rivastigmine—Alzheimer's disease	0.000226	0.00171	CcSEcCtD
Triamcinolone—Loss of consciousness—Memantine—Alzheimer's disease	0.000226	0.00171	CcSEcCtD
Triamcinolone—Syncope—Rivastigmine—Alzheimer's disease	0.000226	0.0017	CcSEcCtD
Triamcinolone—NR3C1—telencephalon—Alzheimer's disease	0.000226	0.0442	CbGeAlD
Triamcinolone—Cough—Memantine—Alzheimer's disease	0.000225	0.00169	CcSEcCtD
Triamcinolone—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000224	0.00169	CcSEcCtD
Triamcinolone—Convulsion—Memantine—Alzheimer's disease	0.000223	0.00168	CcSEcCtD
Triamcinolone—Hypertension—Memantine—Alzheimer's disease	0.000222	0.00168	CcSEcCtD
Triamcinolone—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000221	0.00167	CcSEcCtD
Triamcinolone—Hypersensitivity—Galantamine—Alzheimer's disease	0.00022	0.00166	CcSEcCtD
Triamcinolone—Cough—Rivastigmine—Alzheimer's disease	0.00022	0.00166	CcSEcCtD
Triamcinolone—Myalgia—Memantine—Alzheimer's disease	0.000219	0.00165	CcSEcCtD
Triamcinolone—Convulsion—Rivastigmine—Alzheimer's disease	0.000218	0.00165	CcSEcCtD
Triamcinolone—Hypertension—Rivastigmine—Alzheimer's disease	0.000218	0.00164	CcSEcCtD
Triamcinolone—Discomfort—Memantine—Alzheimer's disease	0.000217	0.00163	CcSEcCtD
Triamcinolone—Myalgia—Rivastigmine—Alzheimer's disease	0.000215	0.00162	CcSEcCtD
Triamcinolone—Dry mouth—Memantine—Alzheimer's disease	0.000214	0.00162	CcSEcCtD
Triamcinolone—Asthenia—Galantamine—Alzheimer's disease	0.000214	0.00162	CcSEcCtD
Triamcinolone—PTGS2—forebrain—Alzheimer's disease	0.000213	0.0416	CbGeAlD
Triamcinolone—Discomfort—Rivastigmine—Alzheimer's disease	0.000212	0.0016	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000211	0.00159	CcSEcCtD
Triamcinolone—Oedema—Memantine—Alzheimer's disease	0.00021	0.00158	CcSEcCtD
Triamcinolone—Dry mouth—Rivastigmine—Alzheimer's disease	0.00021	0.00158	CcSEcCtD
Triamcinolone—Insomnia—Donepezil—Alzheimer's disease	0.000209	0.00158	CcSEcCtD
Triamcinolone—Infection—Memantine—Alzheimer's disease	0.000209	0.00157	CcSEcCtD
Triamcinolone—Paraesthesia—Donepezil—Alzheimer's disease	0.000208	0.00157	CcSEcCtD
Triamcinolone—Shock—Memantine—Alzheimer's disease	0.000207	0.00156	CcSEcCtD
Triamcinolone—Dyspnoea—Donepezil—Alzheimer's disease	0.000206	0.00156	CcSEcCtD
Triamcinolone—Oedema—Rivastigmine—Alzheimer's disease	0.000206	0.00155	CcSEcCtD
Triamcinolone—Tachycardia—Memantine—Alzheimer's disease	0.000205	0.00155	CcSEcCtD
Triamcinolone—Infection—Rivastigmine—Alzheimer's disease	0.000204	0.00154	CcSEcCtD
Triamcinolone—Dyspepsia—Donepezil—Alzheimer's disease	0.000204	0.00154	CcSEcCtD
Triamcinolone—Hyperhidrosis—Memantine—Alzheimer's disease	0.000203	0.00153	CcSEcCtD
Triamcinolone—Shock—Rivastigmine—Alzheimer's disease	0.000202	0.00153	CcSEcCtD
Triamcinolone—Tachycardia—Rivastigmine—Alzheimer's disease	0.000201	0.00151	CcSEcCtD
Triamcinolone—Fatigue—Donepezil—Alzheimer's disease	0.0002	0.0015	CcSEcCtD
Triamcinolone—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000199	0.0015	CcSEcCtD
Triamcinolone—Pain—Donepezil—Alzheimer's disease	0.000198	0.00149	CcSEcCtD
Triamcinolone—Dizziness—Galantamine—Alzheimer's disease	0.000198	0.00149	CcSEcCtD
Triamcinolone—PTGS2—telencephalon—Alzheimer's disease	0.000195	0.0383	CbGeAlD
Triamcinolone—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000192	0.00144	CcSEcCtD
Triamcinolone—Feeling abnormal—Donepezil—Alzheimer's disease	0.000191	0.00144	CcSEcCtD
Triamcinolone—Insomnia—Memantine—Alzheimer's disease	0.00019	0.00143	CcSEcCtD
Triamcinolone—Vomiting—Galantamine—Alzheimer's disease	0.00019	0.00143	CcSEcCtD
Triamcinolone—Paraesthesia—Memantine—Alzheimer's disease	0.000189	0.00142	CcSEcCtD
Triamcinolone—Rash—Galantamine—Alzheimer's disease	0.000188	0.00142	CcSEcCtD
Triamcinolone—Dermatitis—Galantamine—Alzheimer's disease	0.000188	0.00142	CcSEcCtD
Triamcinolone—Dyspnoea—Memantine—Alzheimer's disease	0.000187	0.00141	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000187	0.00141	CcSEcCtD
Triamcinolone—Headache—Galantamine—Alzheimer's disease	0.000187	0.00141	CcSEcCtD
Triamcinolone—Insomnia—Rivastigmine—Alzheimer's disease	0.000186	0.0014	CcSEcCtD
Triamcinolone—Dyspepsia—Memantine—Alzheimer's disease	0.000185	0.00139	CcSEcCtD
Triamcinolone—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000185	0.00139	CcSEcCtD
Triamcinolone—Urticaria—Donepezil—Alzheimer's disease	0.000184	0.00139	CcSEcCtD
Triamcinolone—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000183	0.00138	CcSEcCtD
Triamcinolone—Body temperature increased—Donepezil—Alzheimer's disease	0.000183	0.00138	CcSEcCtD
Triamcinolone—Fatigue—Memantine—Alzheimer's disease	0.000181	0.00137	CcSEcCtD
Triamcinolone—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000181	0.00136	CcSEcCtD
Triamcinolone—Pain—Memantine—Alzheimer's disease	0.00018	0.00136	CcSEcCtD
Triamcinolone—Nausea—Galantamine—Alzheimer's disease	0.000177	0.00134	CcSEcCtD
Triamcinolone—Fatigue—Rivastigmine—Alzheimer's disease	0.000177	0.00134	CcSEcCtD
Triamcinolone—Pain—Rivastigmine—Alzheimer's disease	0.000176	0.00133	CcSEcCtD
Triamcinolone—Feeling abnormal—Memantine—Alzheimer's disease	0.000173	0.00131	CcSEcCtD
Triamcinolone—Hypersensitivity—Donepezil—Alzheimer's disease	0.000171	0.00129	CcSEcCtD
Triamcinolone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000169	0.00128	CcSEcCtD
Triamcinolone—Urticaria—Memantine—Alzheimer's disease	0.000167	0.00126	CcSEcCtD
Triamcinolone—Body temperature increased—Memantine—Alzheimer's disease	0.000166	0.00125	CcSEcCtD
Triamcinolone—Asthenia—Donepezil—Alzheimer's disease	0.000166	0.00125	CcSEcCtD
Triamcinolone—Pruritus—Donepezil—Alzheimer's disease	0.000164	0.00123	CcSEcCtD
Triamcinolone—Urticaria—Rivastigmine—Alzheimer's disease	0.000163	0.00123	CcSEcCtD
Triamcinolone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000163	0.00123	CcSEcCtD
Triamcinolone—Hypersensitivity—Memantine—Alzheimer's disease	0.000155	0.00117	CcSEcCtD
Triamcinolone—Dizziness—Donepezil—Alzheimer's disease	0.000153	0.00115	CcSEcCtD
Triamcinolone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000152	0.00114	CcSEcCtD
Triamcinolone—Asthenia—Memantine—Alzheimer's disease	0.000151	0.00114	CcSEcCtD
Triamcinolone—BCHE—nervous system—Alzheimer's disease	0.00015	0.0293	CbGeAlD
Triamcinolone—Pruritus—Memantine—Alzheimer's disease	0.000149	0.00112	CcSEcCtD
Triamcinolone—Asthenia—Rivastigmine—Alzheimer's disease	0.000148	0.00111	CcSEcCtD
Triamcinolone—Vomiting—Donepezil—Alzheimer's disease	0.000147	0.00111	CcSEcCtD
Triamcinolone—Rash—Donepezil—Alzheimer's disease	0.000146	0.0011	CcSEcCtD
Triamcinolone—Dermatitis—Donepezil—Alzheimer's disease	0.000146	0.0011	CcSEcCtD
Triamcinolone—Pruritus—Rivastigmine—Alzheimer's disease	0.000145	0.0011	CcSEcCtD
Triamcinolone—Headache—Donepezil—Alzheimer's disease	0.000145	0.00109	CcSEcCtD
Triamcinolone—BCHE—central nervous system—Alzheimer's disease	0.000144	0.0282	CbGeAlD
Triamcinolone—BCHE—cerebellum—Alzheimer's disease	0.000141	0.0276	CbGeAlD
Triamcinolone—Dizziness—Memantine—Alzheimer's disease	0.000139	0.00105	CcSEcCtD
Triamcinolone—Nausea—Donepezil—Alzheimer's disease	0.000138	0.00104	CcSEcCtD
Triamcinolone—Dizziness—Rivastigmine—Alzheimer's disease	0.000136	0.00103	CcSEcCtD
Triamcinolone—Vomiting—Memantine—Alzheimer's disease	0.000134	0.00101	CcSEcCtD
Triamcinolone—NR3C1—nervous system—Alzheimer's disease	0.000133	0.0261	CbGeAlD
Triamcinolone—Rash—Memantine—Alzheimer's disease	0.000133	0.000999	CcSEcCtD
Triamcinolone—Dermatitis—Memantine—Alzheimer's disease	0.000132	0.000998	CcSEcCtD
Triamcinolone—Headache—Memantine—Alzheimer's disease	0.000132	0.000993	CcSEcCtD
Triamcinolone—Vomiting—Rivastigmine—Alzheimer's disease	0.000131	0.000986	CcSEcCtD
Triamcinolone—Rash—Rivastigmine—Alzheimer's disease	0.00013	0.000977	CcSEcCtD
Triamcinolone—Dermatitis—Rivastigmine—Alzheimer's disease	0.00013	0.000977	CcSEcCtD
Triamcinolone—Headache—Rivastigmine—Alzheimer's disease	0.000129	0.000971	CcSEcCtD
Triamcinolone—NR3C1—central nervous system—Alzheimer's disease	0.000128	0.0251	CbGeAlD
Triamcinolone—NR3C1—cerebellum—Alzheimer's disease	0.000125	0.0246	CbGeAlD
Triamcinolone—Nausea—Memantine—Alzheimer's disease	0.000125	0.000941	CcSEcCtD
Triamcinolone—Nausea—Rivastigmine—Alzheimer's disease	0.000122	0.000921	CcSEcCtD
Triamcinolone—PTGS2—nervous system—Alzheimer's disease	0.000115	0.0226	CbGeAlD
Triamcinolone—BCHE—brain—Alzheimer's disease	0.000114	0.0224	CbGeAlD
Triamcinolone—PTGS2—central nervous system—Alzheimer's disease	0.000111	0.0218	CbGeAlD
Triamcinolone—PTGS2—cerebellum—Alzheimer's disease	0.000109	0.0213	CbGeAlD
Triamcinolone—NR3C1—brain—Alzheimer's disease	0.000102	0.02	CbGeAlD
Triamcinolone—CYP3A4—nervous system—Alzheimer's disease	0.000101	0.0197	CbGeAlD
Triamcinolone—CYP3A4—central nervous system—Alzheimer's disease	9.71e-05	0.019	CbGeAlD
Triamcinolone—PTGS2—brain—Alzheimer's disease	8.82e-05	0.0173	CbGeAlD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	5.43e-05	0.0016	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	5.39e-05	0.00159	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	5.3e-05	0.00157	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—DHCR24—Alzheimer's disease	5.23e-05	0.00154	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—ADAMTS4—Alzheimer's disease	5.23e-05	0.00154	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	5.22e-05	0.00154	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PHF1—Alzheimer's disease	5.19e-05	0.00153	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—INS—Alzheimer's disease	5.19e-05	0.00153	CbGpPWpGaD
Triamcinolone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Alzheimer's disease	5.18e-05	0.00153	CbGpPWpGaD
Triamcinolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	5.12e-05	0.00151	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—PPARG—Alzheimer's disease	5.11e-05	0.00151	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—CCL2—Alzheimer's disease	5.1e-05	0.00151	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—CREB1—Alzheimer's disease	5.04e-05	0.00149	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—INS—Alzheimer's disease	5.01e-05	0.00148	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Alzheimer's disease	4.95e-05	0.00146	CbGpPWpGaD
Triamcinolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	4.94e-05	0.00146	CbGpPWpGaD
Triamcinolone—NR3C1—Endoderm Differentiation—TGFB1—Alzheimer's disease	4.88e-05	0.00144	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	4.88e-05	0.00144	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IGF1—Alzheimer's disease	4.84e-05	0.00143	CbGpPWpGaD
Triamcinolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	4.8e-05	0.00142	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—LEP—Alzheimer's disease	4.8e-05	0.00142	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	4.77e-05	0.00141	CbGpPWpGaD
Triamcinolone—PTGS2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	4.72e-05	0.00139	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	4.59e-05	0.00135	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—BCL2—Alzheimer's disease	4.54e-05	0.00134	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—NOS2—Alzheimer's disease	4.47e-05	0.00132	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CA4—Alzheimer's disease	4.45e-05	0.00131	CbGpPWpGaD
Triamcinolone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Alzheimer's disease	4.41e-05	0.0013	CbGpPWpGaD
Triamcinolone—Fluoxymesterone—ESR1—Alzheimer's disease	4.39e-05	0.374	CrCbGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	4.35e-05	0.00128	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	4.35e-05	0.00128	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ITM2B—Alzheimer's disease	4.3e-05	0.00127	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—MME—Alzheimer's disease	4.26e-05	0.00126	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GAPDHS—Alzheimer's disease	4.18e-05	0.00123	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	4.16e-05	0.00123	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—PRKCG—Alzheimer's disease	4.06e-05	0.0012	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CCL2—Alzheimer's disease	4.04e-05	0.00119	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ATP5A1—Alzheimer's disease	3.96e-05	0.00117	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—HSPD1—Alzheimer's disease	3.96e-05	0.00117	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	3.93e-05	0.00116	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—TP53—Alzheimer's disease	3.92e-05	0.00116	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL1B—Alzheimer's disease	3.87e-05	0.00114	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	3.87e-05	0.00114	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PLD3—Alzheimer's disease	3.78e-05	0.00112	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	3.78e-05	0.00112	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	3.74e-05	0.0011	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	3.66e-05	0.00108	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HSD17B10—Alzheimer's disease	3.62e-05	0.00107	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—DHCR24—Alzheimer's disease	3.6e-05	0.00106	CbGpPWpGaD
Triamcinolone—NR3C1—AP-1 transcription factor network—IL6—Alzheimer's disease	3.59e-05	0.00106	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	3.54e-05	0.00105	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—CALM1—Alzheimer's disease	3.52e-05	0.00104	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP46A1—Alzheimer's disease	3.49e-05	0.00103	CbGpPWpGaD
Triamcinolone—Dexamethasone—NOS2—Alzheimer's disease	3.47e-05	0.295	CrCbGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—Alzheimer's disease	3.46e-05	0.00102	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GAPDHS—Alzheimer's disease	3.44e-05	0.00101	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ND1—Alzheimer's disease	3.37e-05	0.000995	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	3.36e-05	0.000991	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—EIF2S1—Alzheimer's disease	3.35e-05	0.000988	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—TFAM—Alzheimer's disease	3.35e-05	0.000988	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—ACHE—Alzheimer's disease	3.27e-05	0.000964	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	3.23e-05	0.000954	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	3.22e-05	0.000951	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—Alzheimer's disease	3.16e-05	0.000934	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	3.12e-05	0.00092	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CTSD—Alzheimer's disease	3.09e-05	0.000913	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL1B—Alzheimer's disease	3.06e-05	0.000904	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CA4—Alzheimer's disease	3.06e-05	0.000903	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—CASP3—Alzheimer's disease	3.05e-05	0.000901	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	3.01e-05	0.000889	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—CREB1—Alzheimer's disease	3.01e-05	0.000889	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.99e-05	0.000883	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TTR—Alzheimer's disease	2.98e-05	0.000879	CbGpPWpGaD
Triamcinolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	2.95e-05	0.00087	CbGpPWpGaD
Triamcinolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	2.92e-05	0.000862	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	2.9e-05	0.000857	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—GSK3A—Alzheimer's disease	2.89e-05	0.000855	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GAPDHS—Alzheimer's disease	2.88e-05	0.000849	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—Alzheimer's disease	2.81e-05	0.000829	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	2.81e-05	0.000828	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	2.77e-05	0.000819	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—ACE—Alzheimer's disease	2.76e-05	0.000814	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	2.73e-05	0.000807	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ATP5A1—Alzheimer's disease	2.73e-05	0.000805	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	2.72e-05	0.000803	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—Alzheimer's disease	2.71e-05	0.000801	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	2.7e-05	0.000797	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.68e-05	0.000792	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PLD3—Alzheimer's disease	2.6e-05	0.000768	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.6e-05	0.000768	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	2.6e-05	0.000766	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.57e-05	0.000759	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HSD17B10—Alzheimer's disease	2.49e-05	0.000737	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.44e-05	0.00072	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP46A1—Alzheimer's disease	2.4e-05	0.000709	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TGFB1—Alzheimer's disease	2.38e-05	0.000702	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	2.36e-05	0.000698	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	2.36e-05	0.000695	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	2.34e-05	0.000692	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ND1—Alzheimer's disease	2.32e-05	0.000685	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	2.27e-05	0.000669	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL6—Alzheimer's disease	2.27e-05	0.000669	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—Alzheimer's disease	2.22e-05	0.000656	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SNCA—Alzheimer's disease	2.21e-05	0.000654	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—IGF2—Alzheimer's disease	2.2e-05	0.00065	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IL6—Alzheimer's disease	2.19e-05	0.000646	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CHAT—Alzheimer's disease	2.17e-05	0.000641	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—TPI1—Alzheimer's disease	2.17e-05	0.000641	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—MAOB—Alzheimer's disease	2.08e-05	0.000615	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.08e-05	0.000613	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.07e-05	0.000612	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	2.04e-05	0.000603	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	2.01e-05	0.000595	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GAPDH—Alzheimer's disease	2e-05	0.000592	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.98e-05	0.000585	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	1.98e-05	0.000583	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PSENEN—Alzheimer's disease	1.97e-05	0.000583	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.96e-05	0.00058	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TP53—Alzheimer's disease	1.96e-05	0.000578	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APH1A—Alzheimer's disease	1.95e-05	0.000574	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—A2M—Alzheimer's disease	1.94e-05	0.000571	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.91e-05	0.000564	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NCSTN—Alzheimer's disease	1.89e-05	0.000559	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	1.89e-05	0.000558	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	1.86e-05	0.00055	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LRP1—Alzheimer's disease	1.85e-05	0.000546	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL6—Alzheimer's disease	1.79e-05	0.000529	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.79e-05	0.000528	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TPI1—Alzheimer's disease	1.78e-05	0.000527	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.76e-05	0.00052	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.73e-05	0.000509	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—LEP—Alzheimer's disease	1.71e-05	0.000505	CbGpPWpGaD
Triamcinolone—Betamethasone—PTGS2—Alzheimer's disease	1.71e-05	0.146	CrCbGaD
Triamcinolone—BCHE—Metabolism—ACHE—Alzheimer's disease	1.68e-05	0.000497	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EIF2AK2—Alzheimer's disease	1.68e-05	0.000495	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—INPP5D—Alzheimer's disease	1.66e-05	0.000491	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GAPDH—Alzheimer's disease	1.65e-05	0.000486	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.63e-05	0.00048	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.62e-05	0.000478	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—F2—Alzheimer's disease	1.61e-05	0.000477	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS1—Alzheimer's disease	1.58e-05	0.000466	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ENO1—Alzheimer's disease	1.58e-05	0.000466	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.57e-05	0.000464	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP2D6—Alzheimer's disease	1.55e-05	0.000457	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PSEN2—Alzheimer's disease	1.54e-05	0.000455	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.51e-05	0.000446	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CST3—Alzheimer's disease	1.51e-05	0.000445	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TPI1—Alzheimer's disease	1.49e-05	0.000441	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CHAT—Alzheimer's disease	1.49e-05	0.000441	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—INS—Alzheimer's disease	1.46e-05	0.000432	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CCL2—Alzheimer's disease	1.44e-05	0.000425	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—MAOB—Alzheimer's disease	1.43e-05	0.000423	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—IGF1—Alzheimer's disease	1.41e-05	0.000418	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IAPP—Alzheimer's disease	1.41e-05	0.000416	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PLCB1—Alzheimer's disease	1.38e-05	0.000409	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GAPDH—Alzheimer's disease	1.38e-05	0.000407	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.36e-05	0.000403	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	1.36e-05	0.000401	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.35e-05	0.000399	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ABCA1—Alzheimer's disease	1.34e-05	0.000396	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.34e-05	0.000395	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—A2M—Alzheimer's disease	1.33e-05	0.000393	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.33e-05	0.000393	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ENO1—Alzheimer's disease	1.3e-05	0.000383	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PPP3CA—Alzheimer's disease	1.29e-05	0.000381	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.26e-05	0.000371	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GAB2—Alzheimer's disease	1.24e-05	0.000365	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GSK3A—Alzheimer's disease	1.23e-05	0.000362	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APP—Alzheimer's disease	1.21e-05	0.000356	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.19e-05	0.000352	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.19e-05	0.000351	CbGpPWpGaD
Triamcinolone—Dexamethasone—CYP2D6—Alzheimer's disease	1.18e-05	0.101	CrCbGaD
Triamcinolone—PTGS2—Metabolism—ACHE—Alzheimer's disease	1.16e-05	0.000342	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARGC1A—Alzheimer's disease	1.16e-05	0.000341	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HMOX1—Alzheimer's disease	1.15e-05	0.00034	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—INPP5D—Alzheimer's disease	1.15e-05	0.000338	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.14e-05	0.000336	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.12e-05	0.000332	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.09e-05	0.000322	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PTGS1—Alzheimer's disease	1.09e-05	0.000321	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ENO1—Alzheimer's disease	1.09e-05	0.000321	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP2D6—Alzheimer's disease	1.06e-05	0.000314	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LPL—Alzheimer's disease	1.05e-05	0.000311	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.05e-05	0.00031	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ADAM10—Alzheimer's disease	1.04e-05	0.000306	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.01e-05	0.000299	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—BCHE—Alzheimer's disease	1.01e-05	0.000298	CbGpPWpGaD
Triamcinolone—Dexamethasone—PTGS2—Alzheimer's disease	9.95e-06	0.0847	CrCbGaD
Triamcinolone—NR3C1—Gene Expression—ESR1—Alzheimer's disease	9.84e-06	0.00029	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PLCB1—Alzheimer's disease	9.53e-06	0.000281	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	9.51e-06	0.000281	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—MTHFR—Alzheimer's disease	9.48e-06	0.00028	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCA1—Alzheimer's disease	9.23e-06	0.000273	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PPARG—Alzheimer's disease	8.98e-06	0.000265	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CALM1—Alzheimer's disease	8.85e-06	0.000261	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—APOE—Alzheimer's disease	8.82e-06	0.00026	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CAV1—Alzheimer's disease	8.74e-06	0.000258	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LPL—Alzheimer's disease	8.65e-06	0.000255	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRKCG—Alzheimer's disease	8.41e-06	0.000248	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CCR5—Alzheimer's disease	7.97e-06	0.000235	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARGC1A—Alzheimer's disease	7.96e-06	0.000235	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HMOX1—Alzheimer's disease	7.92e-06	0.000234	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTHFR—Alzheimer's disease	7.79e-06	0.00023	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARG—Alzheimer's disease	7.69e-06	0.000227	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—INS—Alzheimer's disease	7.54e-06	0.000223	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CALM1—Alzheimer's disease	7.28e-06	0.000215	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APOE—Alzheimer's disease	7.25e-06	0.000214	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LPL—Alzheimer's disease	7.25e-06	0.000214	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CAV1—Alzheimer's disease	7.19e-06	0.000212	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOS2—Alzheimer's disease	6.76e-06	0.0002	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOTCH1—Alzheimer's disease	6.69e-06	0.000198	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NOS3—Alzheimer's disease	6.61e-06	0.000195	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.53e-06	0.000193	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.53e-06	0.000193	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—MTHFR—Alzheimer's disease	6.52e-06	0.000193	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GSK3B—Alzheimer's disease	6.28e-06	0.000185	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.26e-06	0.000185	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CREB1—Alzheimer's disease	6.23e-06	0.000184	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—INS—Alzheimer's disease	6.2e-06	0.000183	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CALM1—Alzheimer's disease	6.09e-06	0.00018	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—APOE—Alzheimer's disease	6.07e-06	0.000179	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS2—Alzheimer's disease	6.05e-06	0.000178	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	6.02e-06	0.000178	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CAV1—Alzheimer's disease	6.02e-06	0.000178	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.82e-06	0.000172	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOS3—Alzheimer's disease	5.43e-06	0.00016	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARG—Alzheimer's disease	5.29e-06	0.000156	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—INS—Alzheimer's disease	5.19e-06	0.000153	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.06e-06	0.000149	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5e-06	0.000148	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.74e-06	0.00014	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.74e-06	0.00014	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.65e-06	0.000137	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NOS3—Alzheimer's disease	4.55e-06	0.000134	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.41e-06	0.00013	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.16e-06	0.000123	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.03e-06	0.000119	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFB1—Alzheimer's disease	3.59e-06	0.000106	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—AKT1—Alzheimer's disease	3.55e-06	0.000105	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.48e-06	0.000103	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.46e-06	0.000102	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.16e-06	9.34e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKT1—Alzheimer's disease	3.04e-06	8.97e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.85e-06	8.41e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—Alzheimer's disease	2.71e-06	7.99e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.66e-06	7.86e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.65e-06	7.83e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.63e-06	7.76e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT1—Alzheimer's disease	2.5e-06	7.37e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.31e-06	6.82e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—INS—Alzheimer's disease	2.27e-06	6.69e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKT1—Alzheimer's disease	2.09e-06	6.17e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.99e-06	5.87e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.82e-06	5.37e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKT1—Alzheimer's disease	9.13e-07	2.7e-05	CbGpPWpGaD
